Loading…
β-Ureidopropionase deficiency: A novel inborn error of metabolism discovered using NMR spectroscopy on urine
In this work, NMR investigations that led to the discovery of a new inborn error of metabolism, β‐ureidopropionase (UP) deficiency, are reported. 1D 1H‐NMR experiments were performed using a patient's urine. 3‐Ureidopropionic acid was observed in elevated concentrations in the urine spectrum. A...
Saved in:
Published in: | Magnetic resonance in medicine 2001-11, Vol.46 (5), p.1014-1017 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | In this work, NMR investigations that led to the discovery of a new inborn error of metabolism, β‐ureidopropionase (UP) deficiency, are reported. 1D 1H‐NMR experiments were performed using a patient's urine. 3‐Ureidopropionic acid was observed in elevated concentrations in the urine spectrum. A 1D 1H‐1H total correlation spectroscopy (TOCSY) and two heteronuclear 2D NMR techniques (heteronuclear multiple bond correlation (HMBC) and heteronuclear single‐quantum correlation (HSQC)) were used to identify the molecular structure of the compound that caused an unknown doublet resonance at 1.13 ppm. Combining the information from the various NMR spectra, this resonance could be assigned to 3‐ureidoisobutyric acid. These observations suggested a deficiency of UP. With 1D 1H‐NMR spectroscopy, UP deficiency can be easily diagnosed. The 1H‐NMR spectrum can also be used to diagnose patients suffering from other inborn errors of metabolism in the pyrimidine degradation pathway. Magn Reson Med 46:1014–1017, 2001. © 2001 Wiley‐Liss, Inc. |
---|---|
ISSN: | 0740-3194 1522-2594 |
DOI: | 10.1002/mrm.1289 |